It took over six years, 20+ visits, participation in two clinical drug trials and more to convince this physician patient the time was right to try deep brain stimulation. We share caregiving lessons learned along the way.
The Director of our Center for Neurological Restoration explains this designation from the Parkinson’s Foundation, from the application process through the benefits for patient care and research.
Tuesdays are Dr. Hubert Fernandez’s favorite day of the week, because that’s when he has 12 slots devoted to virtual visits. The neurologist explains how distance health is transforming the way he practices.
BIIB054 takes aim at alpha-synuclein clusters. A leader of the global SPARK trial explains why it’s the most promising compound yet developed to fight early-stage Parkinson disease.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The International Association of Parkinsonism and Related Disorders has tapped this neurologist to edit its journal and chair the scientific program for its world congress. He shares his plans and distinctly global insights.